RECRUITING

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

Talk to us

Conditions

Lung NeoplasmsLung CancerScreeningSmoking

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.

Official Title

Lung B.A.S.E.S 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Assessing Incidence and Stage of Lung Cancer Diagnosis in Subjects Ages 40-54 With a 30 Pack Year History or More Within North and South Carolina

Quick Facts

Study Start:2021-01-07
Study Completion:2025-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04577599

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 54 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subject must meet all the following applicable inclusion criteria to participate in this study:
  2. 1. Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.
  3. 2. Age 40-54 years at the time of consent.
  4. 3. A positive smoking history of greater/equal to 30 pack years and they are either currently smoking or have quit within the last 15 years.
  5. 4. Ability to read and understand the English and/or Spanish language.
  6. 5. Ability to understand and comply with study procedures for the entire length of the study.
  1. * Subjects meeting any of the criteria below may not participate in the study:
  2. 1. Known diagnosis of lung cancer in the past 5 years.
  3. 2. Any known contraindication to having a low-dose CT Scan.
  4. 3. Known pregnancy.

Contacts and Locations

Study Contact

Darcy Doege, RN
CONTACT
913-424-6431
Darcy.Doege@atriumhealth.org

Principal Investigator

Daniel Carrizosa, MD
PRINCIPAL_INVESTIGATOR
LCI

Study Locations (Sites)

Levine Cancer Institute
Charlotte, North Carolina, 28204
United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

  • Daniel Carrizosa, MD, PRINCIPAL_INVESTIGATOR, LCI

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-01-07
Study Completion Date2025-10-31

Study Record Updates

Study Start Date2021-01-07
Study Completion Date2025-10-31

Terms related to this study

Keywords Provided by Researchers

  • Screening
  • Lung Cancer
  • Smoking

Additional Relevant MeSH Terms

  • Lung Neoplasms
  • Lung Cancer